News

Zeta Global Holdings Corp Faces Class Action Lawsuit for Fraud

Zeta Global Holdings Corp Faces Class Action Lawsuit for Fraud

Zeta Global Holdings Corp Faces Class Action Lawsuit

Pomerantz LLP has recently disclosed the filing of a class action lawsuit against Zeta Global Holdings Corp. This lawsuit concerns claims that the Company and certain executives may have engaged in securities fraud and other illegal business operations. This situation is pressing for those who have experienced losses in their investments related to this company, trading under the ticker symbol ZETA.

Understanding the Allegations Against Zeta

The crux of this legal challenge focuses on the integrity of Zeta's business practices. Allegations suggest that Zeta has been involved in misleading practices that may have inflated its reported revenue figures. The lawsuit comes on the heels of a damaging report from a market research entity that raised significant concerns about the company's data collection methods.

The Role of the Market Research Report

On a notable occasion, a report titled "Zeta Global Holdings Corp: Shams, Scams, and Spam" was published. This document brought to light troubling accusations, including claims that the Company engaged in dubious contracts that allowed for simultaneous buying and selling of consumer data, potentially manipulating revenue reports. Furthermore, the report indicated that much of Zeta's customer data could be sourced from problematic websites, misleading consumers into giving away personal information under false pretenses.

The Impact on Shareholders

As a result of these allegations, the company's stock witnessed a significant drop. On the day the report was released, Zeta's share price fell dramatically, closing at $17.76—a staggering decline of 37.07%, which represented a loss of $10.46 per share. This sharp decline has intensified the concern among shareholders, prompting the need for legal recourse.

What Should Shareholders Know?

Shareholders who may have acquired Zeta securities during the affected time span (referred to as the Class Period) are urged to consider their options carefully. It is essential to act promptly as there are critical deadlines approaching. Investors must file a request to be appointed as Lead Plaintiff if they wish to take part in the class action. The deadline to make these requests is approaching, and anyone interested should ensure they are well-informed about the process.

Contact Information for Interested Parties

For shareholders looking to engage and secure their position in this lawsuit, contacting an attorney with experience in securities law is vital. Relevant parties, including attorney Danielle Peyton at Pomerantz, are available to answer questions and guide affected investors through the process.

The Significance of Legal Representation

Legal representation can prove crucial in securities cases like this, as the complexities of class action lawsuits require expert navigation. Pomerantz LLP, with a longstanding history in class action and securities law, emphasizes its commitment to representing the rights of investors. Their notable track record includes recovering billions of dollars for those harmed by fraudulent practices.

Frequently Asked Questions

What prompted the class action lawsuit against Zeta?

The class action lawsuit was triggered by allegations of securities fraud and unlawful business practices involving misleading revenue reporting and questionable data collection methods.

What is the deadline for filing as a Lead Plaintiff?

Shareholders must act quickly, as the deadline to request appointment as Lead Plaintiff is set for January 21, 2025.

How did the market react to the news?

The stock of Zeta Global Holdings experienced a severe drop of 37.07%, closing at $17.76 per share on the day the damaging report was released.

Who can I contact for more information?

For detailed inquiries regarding the lawsuit, affected shareholders can reach out to Danielle Peyton at Pomerantz LLP for assistance and guidance.

What happens if I do not join the class action?

If shareholders do not join the class action, they may lose the opportunity to recover losses tied to their investment in Zeta Global Holdings.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Nonprofit and Partners Gift Homes to Veterans

Updated Category News Views 100

A Heartfelt Gesture on Veterans Day Now this is the kind of story that gets you right in the gut. On November 9, two veterans, who were likely walking into a golf club thinking it was just another evening, were handed the keys to a future they might have only dreamt of: a mortgage-free home. Operation Finally Home, backed by the big names like Lennar and the patriotic...

Continue Reading
Surprising Week on Wall Street: Chips Drive Gains

Updated Category News Views 141

A Wild Week in Wall Street Well, folks, what a week it’s been on Wall Street. The indexes danced the cha-cha, making gains despite closing Friday on a lower note. Despite the retreat, we've got ourselves a week where the major indexes closed higher than the previous Friday. It's not the usual story, but who ever thought stocks played by the rules? The Nasdaq Composite...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 141

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 83

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
LA Fitness ELEVATE Opens at RITHM: A New Era Dawns

Updated Category News Views 66

Elevating Fitness at RITHM: A New Era Has Begun RD Management just dropped a new ace in Tampa Bay’s hand—LA Fitness ELEVATE at the RITHM at Uptown. They lit up the scene with this 30,000-square-foot beast of a gym, and I’ll tell you, it’s not your standard run-of-the-mill joint. When you toss twelve-and-a-half million bucks into a pot, you're aiming to lure folks...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 99

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 155

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Gemmy's Holiday Lights: Bright Ideas for 2026

Updated Category News Views 149

Deep in the heart of Dallas, Gemmy Industries is out to sprinkle a bit of magic over the holiday season for 2026. This ain't your grandma's string lights we're talkin' about here. We're diving headfirst into a new world of seasonal decor with tech-driven lights that look like they came straight outta a winter wonderland. And hey, if Walmart's set to host this lineup, you...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 177

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading

Top 5 Most Recently Viewed Articles

NexPoint Capital Launches Tender Offer for Shareholders

Updated Category News Views 217

NexPoint Capital Begins Tender Offer for Its Common Stock NexPoint Capital, Inc. (the "Company"), a publicly registered business development company expertly managed by NexPoint Advisors, L.P., is set to kick off a voluntary tender offer aimed at going after up to 2.5% of its outstanding common shares. This offer is designed to provide shareholders an opportunity to sell...

Continue Reading
Experience the Winter Wheat Wonderland Pop-Up by Maker's Mark

Updated Category News Views 223

Immerse Yourself in Maker's Mark's Winter Wheat Wonderland Get ready to experience something truly unique this holiday season as Maker's Mark unveils its enchanting pop-up event, the Winter Wheat Wonderland. This special event will take the vibrant spirit of Kentucky bourbon to the heart of New York City, creating a magical atmosphere for all attendees. Details of the...

Continue Reading
Innovative Muscle Composition Study Enhances Liver Transplant Care

Updated Category News Views 202

Assessment of Muscle Composition in Liver Transplant Candidates In a groundbreaking study, the utilization of AMRA Profiler 4, an advanced body-composition analysis device, was analyzed for its effectiveness in evaluating muscle composition among liver transplant candidates suffering from end-stage liver disease (ESLD). This study aims to shed light on critical health...

Continue Reading
Hansa Biopharma's Major Milestones Anticipated in 2025

Updated Category News Views 688

Hansa Biopharma's Participation in Healthcare Conferences Hansa Biopharma AB, a pioneering biopharmaceutical company, is set to make a significant presence at the 2025 J.P. Morgan Healthcare Conference. The company is renowned for its innovative approaches in addressing rare immunological disorders and has been actively engaged in developing novel therapies. This...

Continue Reading
AI for Customer Service: The Next Big Market Leap Ahead

Updated Category News Views 137

AI for Customer Service Market Growth Overview The AI for customer service market is on a remarkable trajectory, set to expand significantly over the next few years. Current projections indicate that the market size will grow from USD 12.06 billion in the near term to an impressive USD 47.82 billion by the end of the decade, achieving a compound annual growth rate (CAGR)...

Continue Reading